Evolution of the Dmt-Tic Pharmacophore
J ournal of Medicinal Chemistry, 1997, Vol. 40, No. 19 3107
(24) Balboni, G.; Guerrini, R.; Salvadori, S.; Tomatis, R.; Bryant, S.
D.; Bianchi, C.; Attila, M.; Lazarus, L. H. Opioid diketo-
piperazines: Synthesis and activity of a unique class of δ opioid
antagonists. Biol. Chem. Hoppe Seyler 1997, 378, 19-29.
(25) Bryant, S. D.; Balboni, G.; Guerrini, R.; Salvadori, S.; Tomatis,
R.; Lazarus, L. H. Opioid diketopiperazines: Refinement of the
δ opioid antagonist pharmacophore. Biol. Chem. Hoppe Seyler
1997, 378, 107-114.
(26) Salvadori, S.; Bryant, S. D.; Temussi, P. A.; Bundy, D. M.; Attila,
M.; Tomatis, R.; Lazarus, L. H. Relationship between receptor
affinity and topography of N-terminally extended and bridged
[Tyr1 f Asp4]deltorphin C analogues: novel probes for the
δ-opioid receptor. Eur. J . Pharmacol. 1993, 230, 357-361.
(27) Mosberg, H. I.; Heyl, D. L.; Haaseth, R. C.; Omnass, J . R.;
Medzihradsky, F.; Smith, C. B. Cyclic dermorphin-like tetrapep-
tides with δ-opioid receptor selectivity. 3. Effect of residue 3
modification on in vitro opioid activity. Mol. Pharmacol. 1990,
38, 924-928.
(28) (a) Mosberg, H. I.; Lomize, A.; Wang, C.; Kroona, H.; Heyl, D.
L.; Sobszyk-Kojiro, K.; Ma, W.; Mousigan, C.; Porreca, F.
Development of a model for the δ opioid receptor pharmacophore.
1. Conformationally restricted Tyr1 replacements in the cyclic δ
receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]OH (J OM-
13) J . Med. Chem. 1994, 37, 4371-4383. (b) Mosberg, H. I.;
Omnass, J . R.; Lomize, A.; Heyl, D. L.; Nordan, I.; Mousigan,
C.; Davis, P.; Porreca, F. Development of a model for the δ opioid
receptor pharmacophore. 2. Conformationally restricted Phe3
replacements in the cyclic δ receptor selective tetrapeptide Tyr-
c[D-Cys-Phe-D-Pen]OH (J OM-13). J . Med. Chem. 1994, 37,
4384-4391.
(29) To´th, G.; Russell, K. C.; Landis, G.; Kramer, T. H.; Fang, L.;
Knapp, R.; Davis, P.; Burks, T. F.; Yamamura, H. I.; Hruby, V.
J . Ring substituted and other conformationally constrained
tyrosine analogues of [D-Pen2,D-Pen5]enkephalin with δ opioid
receptor selectivity. J . Med. Chem. 1992, 35, 2384-2391.
(30) Shaw, J . S.; Miller, L.; Turnbull, M. J .; Gormally, J . J .; Morley,
J . S. Selective antagonist at the opiate delta-receptor. Life Sci.
1982, 31, 1259-1262.
(39) To´th, G.; Pe´ter, A.; Tourwe´, D.; J aspers, H.; Verheyden, P. M.
F.; To´th, Z. New analogues of deltorphin C and enkephalin-
Val5,6,-Gly7-NH2 with replacement of Phe by âMePhe. In Peptides
1994; Maia, H. L. S., Ed.; ESCOM: Leiden, 1995; pp 335-336.
(40) Benoiton, N. L. Nω-Alkyldiamino acids: Chemistry and proper-
ties. In Chemistry and Biochemistry of Amino Acids, Peptides,
and Proteins; Weinstein, B., Ed.; Marcel Dekker: New York,
1978; pp 163-211.
(41) (a) Tang, Y.; Chen, K.-X.; J iang, H.-L.; Wang, Z.-X.; J i, R.-Y.;
Chi, Z.-Q. Molecular modeling of µ opioid receptor and its
interaction with ohmefentanyl. Acta Pharmacol. Sinica 1996,
17, 156-160. (b) Alkorta, I.; Loew, G. H. A 3D model of the δ
opioid receptor and ligand-receptor complexes. Protein Eng.
1996, 9, 573-583.
(42) (a) Befort, K.; Tabbara, L.; Kling, D.; Maigret, B.; Kieffer, B.
Role of aromatic transmembrane residues of the δ-opioid recep-
tor in ligand recognition. J . Biol. Chem. 1996, 271, 10161-10168.
(b) Valiquette, M.; Vu, H. K.; Yue, S. Y.; Wahlestedt, C.; Walker,
P. Involvement of Trp-284, Val-296, and Val-297 of the human
δ-opioid receptor in binding of δ-selective ligands. J . Biol. Chem.
1996, 271, 18789-18796.
(43) Pepin, M.-C.; Yue, S. Y.; Roberts, E.; Wahlestedt, C.; Walker, P.
Novel “restoration of function” mutagenesis strategy to identify
amino acids of the δ-opioid receptor involved in ligand binding.
J . Biol. Chem. 1997, 272, 9260-9267.
(44) Hruby, V. J .; Gehrig, C. A. Recent developments in the design
of receptor specific opioid peptides. (1989) Med. Res. Rev. 1989,
9, 343-401.
(45) Brandt, W.; Barth, A.; Ho¨ltje, H.-D. A new consistent model
explaining structure (conformation)-activity relationships of
opiates with µ-selectivity. Drug Des. Discovery 1993, 10, 257-
283.
(46) (a) Ro´nai, A. Z.; Botya´nski, J .; Magyar, A.; Borsodi, A.; Benyhe,
S.; Medzihradszky, K. Novel, δ-opioid receptor-selective peptide
antagonists: Demonstration of a possible opioid interaction in
the absence of a protonated nitrogen and attempts to locate the
protonated nitrogen site. Arch. Int. Pharmacodyn. 1993, 323,
114-125. (b) Ro´nai, A. Z.; Magyar, A.; Orosz, G.; Borsodi, A.;
Benyhe, S.; To´th, G.; Mako´, EÄ .; Ka´tay, E.; Babka, E.; Medzi-
hradszky, K. Opioid antagonist properties of the highly δ-recep-
tor-selective Boc-Tyr-Pro-Gly-Phe-Leu-Thr(OtBu) peptide and of
its Phe1 and Mel1 analogues. Arch. Int. Pharmocodyn. 1995, 330,
361-369.
(47) Misicka, A.; Lipkowski, A. W.; Slaninova, J .; Davis, P.; Yama-
mura, H. I.; Porreca, F.; Hruby, V. J . The synthesis and opioid
receptor binding affinities of analogues of dermorphin and its
N-terminal tetrapeptide fragment with dibasic acids in position
2. Life Sci. 1995, 57, 1633-1640.
(31) Choi, H.; Murray, T. F.; DeLander, G. E.; Caldwell, V.; Aldrich,
J . N-Terminal alkylated derivatives of [D-Pro10]dynorphin A-(1-
11) are highly selective for κ-opioid receptors. J . Med. Chem.
1992, 35, 4638-4639.
(32) Kawai, M.; Fukuta, N.; Ito, N.; Kagami, T.; Butsugan, Y.;
Maruyama, M.; Kudo, Y. Preparation and opioid activities of
N-methylated analogs of [D-Ala2,Leu5]enkephalin. Int. J . Pept.
Protein Res. 1990, 35, 452-459.
(33) (a) Tonelli, A. E. The effects of isolated N-methylated residues
on the conformational characteristics of polypeptides. Biopoly-
mers 1976, 15, 1615-1622. (b) Ogawa, H.; Burke, G. T.; Chanley,
J . D.; Katsoyannis, P. G. Effect of N-methylation of selected
peptide bonds on the biological activity of insulin. Int. J . Pept.
Protein Res. 1987, 30, 460-473. (c) Bello, J . Helix formation in
methylated copolymers of lysine and alanine. Biopolymers 1992,
32, 491-496.
(34) Vitoux, B.; Aubry, A.; Chung, M. T.; Marraud, M. N-Methyl
peptides. VII. Conformational perturbations by N-methylation
of model peptides. Int. J . Pept. Protein Res. 1986, 27, 617-632.
(35) (a) Turk, J .; Needleman, P.; Marshall, G. R. Analogues of
bradykinin with restricted conformational freedom. J . Med.
Chem. 1975, 18, 1139-1142. (b) Turk, J .; Needleman, P.;
Marshall, G. R. Analogues of angiotensin II with restricted
conformational freedom, including a new antagonist. Mol. Phar-
macol. 1976, 12, 217-224. (c) Dive, V.; Yiotakis, A.; Roumestand,
C.; Gilquin, B.; Labadie, J .; Toma, F. Peptide inhibitors of E.
collagenolyticium bacterial collagenasesEffect of N-methylation
consequences on biological activity and conformational proper-
ties. Int. J . Pept. Protein Res. 1992, 39, 506-515.
(36) Benedetti, E.; Marsh, R. E.; Goodman, M. Conformational studies
on peptides. X-Ray structure determinations of six N-methylated
cyclic dipeptides derived from alanine, valine, and phenylala-
nine. J . Am. Chem. Soc. 1976, 98, 6676-6684.
(37) (a) Salvadori, S.; Bianchi, C.; Lazarus, L. H.; Scaranari, V.;
Attila, M.; Tomatis, R. Para-Substituted Phe3 deltorphin ana-
logues: Enhanced selectivity of halogenated derivatives for δ
opioid receptor sites. J . Med. Chem. 1992, 35, 4651-4657. (b)
Salvadori, S.; Bryant, S. D.; Bianchi, C.; Balboni, G.; Scaranari,
V; Attila, M; Lazarus, L. H. Phe3-Substituted analogues of
deltorphin C. Spatial conformation and topography of the
aromatic ring in peptide recognition by δ opioid receptors. J .
Med. Chem. 1993, 36, 3748-3756.
(48) (a) Benedetti, E.; Corradini, P.; Pedone, C. Crystal and molecular
structure of L-cis-3,6-dimethyl-2,5-piperazinedione (L-alanyl-L-
alanyl-2,5-diketopiperazine). Biopolymers 1969, 7, 751-764. (b)
Benedetti, E.; Corradini, P.; Pedone, C. The crystal and molec-
ular structure of trans-3,6-dimethyl-2,5-piperazinedione (L-ala-
nyl-L-alanyl-2,5-diketopiperazine). J . Phys. Chem. 1969, 73,
2891-2895.
(49) (a) Kong, H.; Raynor, K.; Yasuda, K.; Moe, S. T.; Portoghese, P.
S.; Bell, G. I.; Reisine, T. A single residue, aspartic acid 95, in
the δ opioid receptor specifies selective high affinity agonist
binding. J . Biol. Chem. 1993, 268, 23055-23058. (b) Claude, P.
A.; Wotta, D. R.; Zhang, X. H.; Prather, P. L.; McGinn, T. M.;
Erickson, L. J .; Loh, H. H.; Law, P. Y. Mutation of a conserved
serine in TM4 of opioid receptors confers full agonistic properties
to classical antagonists. Proc. Natl. Acad. Sci. U.S.A. 1996, 93,
5715-5719.
(50) Moran, S.; Ren, R. X.-F.; Rumney, IV, S.; Kool, E. T. Difluoro-
toluene, a nonpolar isostere for thymine, codes specifically and
efficiently for adenine in DNA replication. J . Am. Chem. Soc.
1997, 119, 2056-2057.
(51) Vaughn, L. K.; Wire, W. S.; Davis, P.; Shimohigashi, Y.; Toth,
G., Knapp, R. J .; Hruby, V. J .; Burks, T. F.; Yamamura, H. I.
Differentiation between rat brain and mouse vas deferens δ
opioid receptors. Eur. J . Pharmacol. 1990, 177, 99-101.
(52) (a) Gacel, G. A.; Fellion, E., Baamonde, A.; Dauge, V.; Roques,
B. P. Synthesis, biochemical and pharmacological properties of
BUBUC, a highly selective and systemically active agonist for
in vivo studies of δ-opioid receptors. Peptides 1990, 11, 983-
988. (b) Hruby, V. J .; Toth, G.; Gehrig, C. A.; Kao, L.-F.; Knapp,
R.; Lui, G. K.; Yamamura, H. I.; Kramer, T. H.; Davis, P.; Burks,
T. F. Topically designed analogues of [D-Pen,D-Pen5]enkephalin.
J . Med. Chem. 1991, 34, 1923-1830. (c) Schiller, P. W.; Wel-
trowska, G.; Nguyen, T. M.-D.; Lemieux, C.; Chung, N. N.;
Marsden, B. J .; Wilkes, B. C. Conformational restriction of the
(38) (a) Hruby, V. J .; To´th, G.; Gehrig, C. A.; Kao, L.-F.; Knapp, R.;
Lui, G. K.; Yamamura, H. I.; Kramer, T. H.; Davis, P.; Burks,
T. F. Topographically designed analogues of [D-Pen,D-Pen5]-
enkephalin. J . Med. Chem. 1991, 34, 1823-1830. (b) He, Y.-B.;
Huang, Z.; Raynor, K.; Reisine, T.; Goodman, M. Syntheses and
conformations of somatostatin-related cyclic hexapeptides in-
corporating specific R- and â-methylated residues. J . Am. Chem.
Soc. 1993, 115, 8066-8072.
phenylalanine residue in
a cyclic opioid peptide analogue:
Effects on receptor selectivity and stereospecificity. J . Med.
Chem. 1991, 34, 3125-3132. (d) Schiller, P. W.; Weltrowska, G.;
Nguyen, T. M.-D.; Wilkes, B. C.; Chung, N. N.; Lemieux, C.
Conformationally restricted deltorphin analogues. J . Med. Chem.
1992, 35, 3956-3961. (e) Misicka, A.; Lipkowski, A. W.; Horvath,